-
公开(公告)号：US20180186880A1
公开(公告)日：2018-07-05
申请号：US15861410
申请日：2018-01-03
CPC分类号： C07K16/2803 , A61P35/00 , C07K16/2827 , C07K16/30 , C07K2317/21 , C07K2317/24 , C07K2317/31 , C07K2317/54 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/92
摘要： Novel monoclonal antibodies directed against immune checkpoint modulator (ICM) proteins TIM-3 and B7-H3 are useful in treating cancer and immune system disorders.
-
公开(公告)号：US20210277116A1
公开(公告)日：2021-09-09
申请号：US17328239
申请日：2021-05-24
摘要： Novel monoclonal antibodies directed against immune checkpoint modulator (ICM) proteins TIM-3 and B7-H3 are useful in treating cancer and immune system disorders.
-
3.发明申请公开(公告)号：US20210054075A1
公开(公告)日：2021-02-25
申请号：US17091526
申请日：2020-11-06
IPC分类号： C07K16/28 , A61K39/395 , A61K45/06
摘要： Monoclonal antibodies derived from the native human repertoire that bind the extracellular portion of Killer IgG Receptor (KIR) and pharmaceutical and veterinary compositions thereof are useful in treating cancer in human and other subjects.
-
4.发明申请公开(公告)号：US20180002420A1
公开(公告)日：2018-01-04
申请号：US15619327
申请日：2017-06-09
IPC分类号： C07K16/28 , A61K39/395 , A61K45/06
摘要： Monoclonal antibodies derived from the native human repertoire that bind the extracellular portion of Killer IgG Receptor (KIR) and pharmaceutical and veterinary compositions thereof are useful in treating cancer in human and other subjects.
-
-
-
搜索结果
4 条记录 (耗时 0.013 秒)
